{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CVKD/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T16:18:40.681Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12040,"canonical_name":"Cadrenal Therapeutics, Inc.","cik":"0001937993","uei":null,"lei":null,"duns":null,"ticker":"CVKD"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":42},"count":42,"timeline":[{"ts":"2026-10-08","kind":"sec.filing","form_type":"S-8","title":"S-8 — Cadrenal Therapeutics, Inc. — 2026-10-08","url_slug":"/sec/cik-0001937993/s-8/0001213900-26-108052","accession_number":"0001213900-26-108052","importance":30},{"ts":"2026-10-07","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-10-07","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-107442","accession_number":"0001213900-26-107442","importance":35},{"ts":"2026-09-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-09-29","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-104647","accession_number":"0001213900-26-104647","importance":35},{"ts":"2026-09-03","kind":"sec.filing","form_type":"S-8","title":"S-8 — Cadrenal Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001937993/s-8/0001213900-26-097282","accession_number":"0001213900-26-097282","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-08-31","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-095394","accession_number":"0001213900-26-095394","importance":35},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Cadrenal Therapeutics, Inc. — 2026-08-13","url_slug":"/sec/cik-0001937993/10-q/0001213900-26-089153","accession_number":"0001213900-26-089153","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-08-13","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-089147","accession_number":"0001213900-26-089147","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cadrenal Therapeutics, Inc. — 2026-08-07","url_slug":"/sec/cik-0001937993/schedule-13g/0001193125-26-339234","accession_number":"0001193125-26-339234","importance":55},{"ts":"2026-08-03","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Cadrenal Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001937993/def-14a/0001213900-26-084710","accession_number":"0001213900-26-084710","importance":40},{"ts":"2026-08-03","kind":"sec.filing","form_type":"ARS","title":"ARS — Cadrenal Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001937993/ars/0001213900-26-084713","accession_number":"0001213900-26-084713","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Cadrenal Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001937993/defa14a/0001213900-26-084716","accession_number":"0001213900-26-084716","importance":30},{"ts":"2026-07-23","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Cadrenal Therapeutics, Inc. — 2026-07-23","url_slug":"/sec/cik-0001937993/pre-14a/0001213900-26-081012","accession_number":"0001213900-26-081012","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-07-21","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-079824","accession_number":"0001213900-26-079824","importance":35},{"ts":"2026-07-20","kind":"sec.filing","form_type":"424B3","title":"424B3 — Cadrenal Therapeutics, Inc. — 2026-07-20","url_slug":"/sec/cik-0001937993/424b3/0001213900-26-079648","accession_number":"0001213900-26-079648","importance":30},{"ts":"2026-07-20","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Cadrenal Therapeutics, Inc. — 2026-07-20","url_slug":"/sec/cik-0001937993/effect/9999999995-26-002367","accession_number":"9999999995-26-002367","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-079176","accession_number":"0001213900-26-079176","importance":35},{"ts":"2026-07-15","kind":"sec.filing","form_type":"D","title":"D — Cadrenal Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0001937993/d/0001213900-26-078373","accession_number":"0001213900-26-078373","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"S-3","title":"S-3 — Cadrenal Therapeutics, Inc. — 2026-07-13","url_slug":"/sec/cik-0001937993/s-3/0001213900-26-077647","accession_number":"0001213900-26-077647","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-07-10","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-077134","accession_number":"0001213900-26-077134","importance":35},{"ts":"2026-07-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-07-01","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-074421","accession_number":"0001213900-26-074421","importance":35},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman and CEO","shares":7400,"price_per_share":3.03,"usd_value":22422,"security_title":"Common Stock","importance":35.022422},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-06-29","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-073213","accession_number":"0001213900-26-073213","importance":35},{"ts":"2026-06-29","kind":"sec.insider.7400","reporter":"Pham Quang X","title":"Chairman and CEO","shares":7400,"price_per_share":3.03,"usd_value":22422,"security_title":"Common Stock","importance":15.022422},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":9029,"price_per_share":3.05,"usd_value":27538,"security_title":"Common Stock","importance":35.02753845},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":2127,"price_per_share":3,"usd_value":6381,"security_title":"Common Stock","importance":35.006381},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":2277,"price_per_share":3.2,"usd_value":7286,"security_title":"Common Stock","importance":35.0072864},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":9167,"price_per_share":3.55,"usd_value":32543,"security_title":"Common Stock","importance":35.03254285},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Cadrenal Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001937993/8-k/0001213900-26-069902","accession_number":"0001213900-26-069902","importance":35},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":513,"price_per_share":3.16,"usd_value":1621,"security_title":"Common Stock","importance":35.00162108},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":3613,"price_per_share":3.18,"usd_value":11489,"security_title":"Common Stock","importance":35.01148934},{"ts":"2026-06-15","kind":"sec.form144","reporter":"Quang X. Pham","title":"Officer","shares":40000,"usd_value":148400,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001628280-26-043385","importance":40.02968},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":3666,"price_per_share":3.58,"usd_value":13124,"security_title":"Common Stock","importance":35.01312428},{"ts":"2026-06-12","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":12996,"price_per_share":3.94,"usd_value":51204,"security_title":"Common Stock","importance":35.05120424},{"ts":"2026-06-11","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":1462,"price_per_share":4.12,"usd_value":6023,"security_title":"Common Stock","importance":35.00602344},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":3500,"price_per_share":4.21,"usd_value":14735,"security_title":"Common Stock","importance":35.014735},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":12992,"price_per_share":4.06,"usd_value":52748,"security_title":"Common Stock","importance":35.05274752},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"Pham Quang X","title":"Chairman, CEO and Interim CFO","shares":5893,"price_per_share":4.38,"usd_value":25811,"security_title":"Common Stock","importance":35.02581134},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Pham Quang X","title":"CEO and Chairman","shares":2064,"price_per_share":4.42,"usd_value":9123,"security_title":"Common Stock","importance":35.00912288},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Pham Quang X","title":"CEO and Chairman","shares":3898,"price_per_share":4.41,"usd_value":17190,"security_title":"Common Stock","importance":35.01719018},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Pham Quang X","title":"CEO and Chairman","shares":2323,"price_per_share":4.26,"usd_value":9896,"security_title":"Common Stock","importance":35.00989598},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Pham Quang X","title":"CEO and Chairman","shares":349,"price_per_share":4.46,"usd_value":1557,"security_title":"Common Stock","importance":35.00155654},{"ts":"2026-05-29","kind":"sec.insider.s","reporter":"Pham Quang X","title":"CEO and Chairman","shares":303,"price_per_share":5.01,"usd_value":1518,"security_title":"Common Stock","importance":35.00151803}]}